| Schedule of Income (Loss) Per Common Share, Basic and Diluted |
Basic and diluted loss per share for the three and nine months ended September 30, 2023 and 2022, respectively, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
|
|
2023 |
|
2022 |
|
2023 |
|
2022 |
| Numerator: |
|
|
|
|
|
|
|
|
| Net loss available to stockholders |
|
$ |
(481,573) |
|
|
$ |
(256,712) |
|
|
$ |
(2,751,711) |
|
|
$ |
(1,023,521) |
|
|
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
|
| Weighted average shares outstanding - Basic |
|
24,850,261 |
|
|
24,850,261 |
|
|
24,850,261 |
|
|
24,850,261 |
|
| Effect of dilutive securities: |
|
|
|
|
|
|
|
|
| Stock options |
|
— |
|
|
— |
|
|
— |
|
|
— |
|
| Weighted average shares outstanding - Diluted |
|
24,850,261 |
|
|
24,850,261 |
|
|
24,850,261 |
|
|
24,850,261 |
|
|
|
|
|
|
|
|
|
|
| Basic loss per share |
|
$ |
(0.02) |
|
|
$ |
(0.01) |
|
|
$ |
(0.11) |
|
|
$ |
(0.04) |
|
| Diluted loss per share |
|
$ |
(0.02) |
|
|
$ |
(0.01) |
|
|
$ |
(0.11) |
|
|
$ |
(0.04) |
|
|
|
|
|
|
|
|
|
|
| Anti-dilutive shares underlying stock options outstanding |
|
1,829,051 |
|
|
971,001 |
|
|
1,829,051 |
|
|
836,001 |
|
|